glp 1 based drugs Another milestone in the evolution of GLP-1-based diabetes therapies Ease your GLP GLP-1 Drugs Use, Risks, and
Description
10.1074/jbc.M307612200 84 MaratheC
REFERENCES Author Diana Girnita Md, PHD Last Updates November 15, 2025 Author View all posts Dr

Exendin-4, a glucagonlike peptide-1 receptor agonist, attenuates breast cancer growth by inhibiting NF-B activation

From Diabetes Breakthrough to Obesity Powerhouse: GLP-1s agonists have revolutionized type 2 diabetes treatment, and now theyre poised to reshape healthcare again

While clinical trials have provided valuable insights, further research is should determine the optimal use of these agents in different heart failure populations
